FrancophonIA/ELRC3.0 huggingface dataset:
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND
Slovenian: PROIZVAJALEC BIOLOŠKE UČINKOVINE IN PROIZVAJALEC ZDRAVILA,
English: Minimum quantity of purified p45 FeLV-envelope antigen: 102 µg
Slovenian: Učinkovina: Minimalna količina prečiščenega antigena ovojnice p 45FeLV: 102 µg.
English: Minimum quantity of purified p45 FeLV-envelope antigen 102 µg
Slovenian: Učinkovina: Minimalna količina prečiščenega antigena ovojnice p 45 FeLV 102 µg
English: In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Slovenian: Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo V primeru nenamernega samoinjiciranja se takoj posvetujte z zdravnikom in mu pokažite navodila za uporabo ali ovojnino.
English: Marketing authorisation holder and manufacturer responsible for the batch release VIRBAC
Slovenian: Imetnik dovoljenja za promet z zdravilom in proizvajalec odgovoren za sproščanje serij VIRBAC
English: EXP {month/year} Once broached use immediately.
Slovenian: Načeto zdravilo uporabite takoj.
English: Excipients:
Slovenian: Inkompatibilnosti:
English: Special precautions to be taken by the person administering the veterinary medicinal product to animals
Slovenian: Posebni previdnostni ukrepi za uporabo pri živalih
English: This overview was last updated in 11-2018.
Slovenian: Povzetek je bil nazadnje posodobljen 11-2018.
English: It should be used in combination with safer sex practices, such as use of condoms.
Slovenian: Uporabljati bi se moral v kombinaciji z varnejšimi spolnimi praksami, na primer uporabo kondomov.
English: In addition, it may be used in adolescents with HIV who are resistant to first-line treatments or who cannot take them because of side effects.
Slovenian: Poleg tega se lahko uporablja tudi pri mladostnikih, ki so okuženi z virusom HIV in so odporni proti zdravilom prve izbire ali teh zaradi neželenih učinkov ne morejo jemati.
English: Emtricitabine/Tenofovir disoproxil Krka received a marketing authorisation valid throughout the EU on 9 December 2016.
Slovenian: Za zdravilo Emtricitabin/dizoproksiltenofovirat Krka je bilo 9. decembra 2016 izdano dovoljenje za promet, veljavno po vsej EU.
English: Further information on Emtricitabine/Tenofovir disoproxil Krka can be found on the Agency's website: www.ema.europa.eu/medicines/human/EPAR/EmtricitabineTenofovir-disoproxil-Krka.
Slovenian: Nadaljnje informacije o zdravilu Emtricitabin/dizoproksiltenofovirat Krka so na voljo na spletni strani agencije: www.ema.europa.eu/medicines/human/EPAR/EmtricitabineTenofovir-disoproxil-Krka.
English: This means that it contains the same active substances and works in the same way as a ‘reference medicine' already authorised in the EU called Truvada.
Slovenian: To pomeni, da vsebuje enaki zdravilni učinkovini in ima enak način delovanja kot referenčno zdravilo Truvada, ki je že odobreno v EU.
English: If patients need to stop taking emtricitabine or tenofovir, or need to take different doses, they will need to take medicines containing emtricitabine or tenofovir disoproxil separately.
Slovenian: Če bi morali bolniki prekiniti jemanje emtricitabina ali tenofovirja oziroma bi bilo treba njune odmerke spremeniti, bodo morali jemati zdravila, ki ločeno vsebujejo emtricitabin ali dizoproksiltenofovirat.
English: Studies on the benefits and risks of the active substances in the authorised uses have already been carried out with the reference medicine, Truvada, and do not need to be repeated for Emtricitabine/Tenofovir disoproxil Krka.
Slovenian: Študije o koristih in tveganjih zdravilnih učinkovin pri dovoljenih uporabah so že bile izvedene z referenčnim zdravilom Truvada, zato jih ni treba ponoviti za zdravilo Emtricitabin/dizoproksiltenofovirat Krka.
English: The European Medicines Agency concluded that, in accordance with EU requirements, Emtricitabine/Tenofovir disoproxil Krka has been shown to have comparable quality and to be bioequivalent to Truvada.
Slovenian: Evropska agencija za zdravila je zaključila, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Emtricitabin/dizoproksiltenofovirat Krka primerljivo raven kakovosti kot referenčno zdravilo Truvada ter da mu je biološko enakovredno.
English: Healthcare professionals will also receive a brochure and reminder card to hand out to individuals receiving the medicine for preexposure prophylaxis.
Slovenian: Zdravstveni delavci bodo prav tako prejeli brošuro in opozorilno kartico za posameznike, ki jemljejo zdravilo za predekspozicijsko profilakso.
English: Because Emtricitabine/Tenofovir disoproxil Krka is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Slovenian: Ker je zdravilo Emtricitabin/dizoproksiltenofovirat Krka generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
English: Side effects reported with Emtricitabine/Tenofovir disoproxil Krka are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu Emtricitabin/dizoproksiltenofovirat Krka, se skrbno ovrednotijo in po potrebi se sprejmejo ukrepi za zaščito bolnikov.
English: An overview of Emtricitabine/Tenofovir disoproxil Krka and why it is authorised in the EU
Slovenian: Pregled zdravila Emtricitabin/dizoproksiltenofovirat Krka in zakaj je odobreno v EU
English: Emtricitabine/Tenofovir disoproxil Krka is available as tablets (200 mg emtricitabine and 245 mg tenofovir disoproxil).
Slovenian: Zdravilo Emtricitabin/dizoproksiltenofovirat Krka je na voljo v obliki tablet (200 mg emtricitabina in 245 mg dizoproksiltenofovirata).
English: For the treatment of HIV-1 infection, Emtricitabine/Tenofovir disoproxil Krka, taken in combination with at least one other antiviral medicine, reduces the amount of HIV in the blood and keeps it at a low level.
Slovenian: Pri zdravljenju okužbe z virusom HIV-1 zdravilo Emtricitabin/dizoproksiltenofovirat Krka v kombinaciji z vsaj enim protivirusnim zdravilom zniža količino virusa HIV v krvi in jo zadržuje na nizki ravni.
English: What measures are being taken to ensure the safe and effective use of Emtricitabine/Tenofovir disoproxil Krka?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Emtricitabin/dizoproksiltenofovirat Krka?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Emtricitabine/Tenofovir disoproxil Krka have also been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in varnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Emtricitabin/dizoproksiltenofovirat Krka upoštevati zdravstveni delavci in bolniki, so vključeni tudi v povzetek glavnih značilnosti zdravila in navodilo za njegovo uporabo.
English: Emtricitabine/Tenofovir disoproxil Krka is an HIV medicine that is used in combination with at least one other HIV medicine to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).
Slovenian: Emtricitabin/dizoproksiltenofovirat Krka je zdravilo proti virusu HIV, ki se uporablja v kombinaciji z vsaj enim drugim zdravilom te vrste za zdravljenje odraslih, okuženih z virusom humane imunske pomanjkljivosti tipa 1 (HIV-1), tj. virusom, ki povzroča sindrom pridobljene imunske pomanjkljivosti (aids).
English: For more information about using Emtricitabine/Tenofovir disoproxil Krka, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Emtricitabin/dizoproksiltenofovirat Krka glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: As for all medicines, data on the use of Emtricitabine/Tenofovir disoproxil Krka are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Emtricitabin/dizoproksiltenofovirat Krka stalno spremljajo.
English: Emtricitabine/Tenofovir disoproxil Krka is also used to help prevent sexually transmitted HIV-1 infection in adults and adolescents who are at high risk of being infected (pre-exposure prophylaxis or PrEP).
Slovenian: Zdravilo Emtricitabin/dizoproksiltenofovirat Krka se uporablja tudi kot pomoč za preprečevanje spolno prenosljive okužbe z virusom HIV-1 pri odraslih in mladostnikih, pri katerih je tveganje za okužbo veliko (predekspozicijska profilaksa oziroma PrEP).
English: As for every medicine, the company provided studies on the quality of Emtricitabine/Tenofovir disoproxil Krka.
Slovenian: Kot to velja za vsako zdravilo, je družba zagotovila študije o kakovosti zdravila Emtricitabin/dizoproksiltenofovirat Krka.
English: Other information about Emtricitabine/Tenofovir disoproxil Krka
Slovenian: Druge informacije o zdravilu Emtricitabin/dizoproksiltenofovirat Krka
English: Both emtricitabine and tenofovir work in similar ways by blocking the activity of reverse transcriptase, an enzyme produced by HIV that allows it to reproduce itself in the cells it has infected.
Slovenian: Emtricitabin in tenofovir podobno zavirata dejavnost reverzne transkriptaze, tj. encima, ki ga tvori virus HIV in ki mu omogoča, da se lahko razmnožuje v celicah, ki jih je virus okužil.
English: What are the benefits and risks of Emtricitabine/Tenofovir disoproxil Krka?
Slovenian: Kakšne so koristi in tveganja, povezani z zdravilom Emtricitabin/dizoproksiltenofovirat Krka?
English: The company that markets Emtricitabine/Tenofovir disoproxil Krka will provide an information pack to doctors which covers the potential harmful effects of Emtricitabine/Tenofovir disoproxil Krka on kidney function, and information about use for pre-exposure prophylaxis.
Slovenian: Družba, ki trži zdravilo Emtricitabin/dizoproksiltenofovirat Krka, bo pripravila informacijsko gradivo za zdravnike, ki bo obsegalo opis možnih škodljivih učinkov zdravila za delovanje ledvic pri jemanju tega zdravila in informacije o njegovi uporabi za predekspozijsko profilakso.
English: Emtricitabine/Tenofovir disoproxil Krka can only be obtained with a prescription and treatment should be started by a doctor who has experience in the management of HIV infection.
Slovenian: Predpisovanje in izdaja zdravila Emtricitabin/dizoproksiltenofovirat Krka je le na recept, zdravljenje z njim pa mora uvesti zdravnik, ki ima izkušnje z zdravljenjem okužbe z virusom HIV.
English: Emtricitabine/Tenofovir disoproxil Krka (emtricitabine / tenofovir disoproxil)
Slovenian: Emtricitabin/dizoproksiltenofovirat Krka (emtricitabin/dizoproksiltenofovirat)
English: Emtricitabine/Tenofovir disoproxil Krka does not cure HIV infection or AIDS, but it holds off the damage to the immune system and the development of infections and diseases associated with AIDS.
Slovenian: Zdravilo ne zdravi okužbe z virusom HIV ali aidsa, lahko pa upočasni slabšanje imunskega sistema ter razvoj okužb in bolezni, povezanih z aidsom.
English: Emtricitabine/Tenofovir disoproxil Krka contains two active substances: emtricitabine, which is a nucleoside reverse transcriptase inhibitor; and tenofovir disoproxil, which is a ‘prodrug' of tenofovir.
Slovenian: Zdravilo Emtricitabin/dizoproksiltenofovirat Krka vsebuje dve zdravilni učinkovini: emtricitabin, ki je nukleozidni zaviralec reverzne transkriptaze, in dizoproksiltenofovirat, ki je „predzdravilo“ tenofovirja.
English: What is Emtricitabine/Tenofovir disoproxil Krka and what is it used for?
Slovenian: Kaj je zdravilo Emtricitabin/dizoproksiltenofovirat Krka in za kaj se uporablja?
English: Therefore, the Agency's view was that, as for Truvada, the benefit of Emtricitabine/Tenofovir disoproxil Krka outweighs the identified risk and it can be authorised for use in the EU.
Slovenian: Zato je menila, da koristi zdravila Emtricitabin/dizoproksiltenofovirat Krka, enako kot pri zdravilu Truvada, odtehtajo znana tveganja in se zdravilo lahko odobri v EU.
English: Why is Emtricitabine/Tenofovir disoproxil Krka authorised in the EU?
Slovenian: Zakaj je bilo zdravilo Pemetreksed Krka odobreno v EU?
English: For pre-exposure prophylaxis of HIV-1 infection, it is expected that Emtricitabine/Tenofovir disoproxil Krka in the blood will stop the virus from multiplying and spreading from the site of infection in case the individual is exposed to the virus.
Slovenian: Pričakuje se, da zdravilo Emtricitabin/dizoproksiltenofovirat Krka v krvi za predekspozicijsko profilakso pred okužbo z virusom HIV-1 v primeru izpostavljenosti posameznika virusu prepreči razmnoževanje in širjenje virusa z mesta okužbe.
English: Emtricitabine/Tenofovir disoproxil Krka contains two active substances, emtricitabine and tenofovir disoproxil.
Slovenian: Zdravilo Emtricitabin/dizoproksiltenofovirat Krka vsebuje dve zdravilni učinkovini, emtricitabin in dizoproksiltenofovirat.
English: How is Emtricitabine/Tenofovir disoproxil Krka used?
Slovenian: Kako se zdravilo Emtricitabin/dizoproksiltenofovirat Krka uporablja?
English: How has Emtricitabine/Tenofovir disoproxil Krka been studied?
Slovenian: Kako je bilo zdravilo Emtricitabin/dizoproksiltenofovirat Krka raziskano?
English: How does Emtricitabine/Tenofovir disoproxil Krka work?
Slovenian: Kako zdravilo Emtricitabin/dizoproksiltenofovirat Krka deluje?
English: Your doctor will decide the appropriate dose for your child.
Slovenian: Vaš zdravnik bo določil primeren odmerek za vašega otroka.
English: In such cases, the Western blot method is negative.
Slovenian: V takšnih primerih je bil izvid na osnovi metode Western blot negativen.
English: - First data-lock point is 30 days later.
Slovenian: - Prva točka zaključitve zbiranja podatkov je 30 dni pozneje.
English: This is because the vaccination may not be recommended, or may need to be delayed.
Slovenian: To je zato, ker cepljenje morda ni priporočljivo ali ga je potrebno opraviti kasneje.
English: • if you have a serious infection with a high temperature (over 38°C).
Slovenian: • če imate resno okužbo z visoko telesno temperaturo (nad 38 °C).
English: - The clock should start from the first Monday after shipment of the first batch of vaccine.
Slovenian: - Ura steče prvi ponedeljek po odpremljenju prve serije cepiva.
English: Loss of appetite
Slovenian: izguba apetita
English: The following principles should be followed when compiling the data:
Slovenian: Pri pripravi podatkov je treba upoštevati naslednja načela:
English: Those which have not yet been entered should be reported in the following SPSUR.
Slovenian: Tiste, ki še niso bili vneseni, je treba prijaviti v naslednjem
English: For further information, see sections 4.4, 4.8 and 5.1.
Slovenian: Za dodatne informacije glejte poglavja 4.4, 4.8. in 5.1.
English: Only spontaneously reported data should be included in the PSUR.
Slovenian: V PSUR je treba vključiti samo spontano prijavljene podatke.
English: Older (>60 years)
Slovenian: Starejše osebe (>60 let)
English: For any information about this medicinal vaccine, please contact the local representative of the Marketing Authorisation Holder:
Slovenian: Za vse informacije o tem cepivu se obrnite na lokalnega predstavnika imetnika dovoljenja za promet:
English: In the event of multiple signals, signal work-up may be prioritised and appropriate timelines for submission of a full signal evaluation report should be provided.
Slovenian: V primeru multiplih signalov je mogoče obdelavi signalov dati prioriteto in zagotoviti je treba ustrezne časovne okvire za predložitev celotnega poročila o ovrednotenju signalov.
English: A short summary should be provided in which validated signals and areas of concern are highlighted, taking into account information arising from the prospective cohort study described in 4.5.
Slovenian: Posredovati je treba kratek povzetek, v katerem so izpostavljeni validirani signali in problematična področja, upoštevaje informacije iz prospektivne kohortne študije, opisane v 4.5.
English: Very common: headache
Slovenian: Zelo pogosti: glavobol
English: The following age groups will be used: < 2 years, 2-8 years, > 9 years.
Slovenian: Uporabljene bodo starostne skupine < 2 leti, od 2 do 8 let,
English: Adjupanrix should be used in accordance with official guidance.
Slovenian: Adjupanrix je treba uporabljati v skladu z uradnimi smernicami.
English: Warning and precautions:
Slovenian: Opozorila in previdnostni ukrepi:
English: In the first few weeks after vaccination with Adjupanrix the results of these tests may not be correct.
Slovenian: V prvih nekaj tednih po cepljenju s cepivom Adjupanrix so lahko rezultati teh preiskav napačni.
English: Date of first authorisation: 19 October 2009 Date of latest renewal: 18 July 2014
Slovenian: Datum zadnjega podaljšanja: 18. julij 2014
English: Currently available data are described in section 4.4, 4.8 and 5.1 but no recommendation on a posology can be made.
Slovenian: Podatki, ki so trenutno na voljo, so opisani v poglavjih 4.4, 4.8 in 5.1, a priporočil za odmerjanje ni mogoče dati.
English: • Serious stabbing or throbbing pain along one or more nerves
Slovenian: • resna zbadajoča ali kljuvajoča bolečina vzdolž enega ali več živcev,
English: These data suggest that the excess risk tends to decline with increasing age at vaccination.
Slovenian: Ti podatki kažejo, da se dodatno tveganje zmanjšuje z naraščajočo starostjo ob cepljenju.
English: Depending on and after implementation of vaccine when first pandemic will take place.
Slovenian: V odvisnosti od in po uvedbi cepiva ob prvem pojavu pandemije.
English: If this is not treated it may lead to shock.
Slovenian: Če ta ni zdravljen, lahko povzroči šok.
English: Moreover, a 6-monthly cycle may be too long to allow assessment of the safety of a vaccine for which high levels of exposure are expected within a short period of time.
Slovenian: Poleg tega utegnejo biti 6-mesečni ciklusi predolgi za oceno varnosti cepiva, ki mu bo v kratkem časovnem obdobju predvidoma izpostavljenih veliko ljudi.
English: Prophylaxis of influenza in an officially declared pandemic situation.
Slovenian: Preprečevanje gripe v uradno razglašenih pandemskih razmerah.
English: The first two injections should be given at the elected date and the two other injections should preferably be given 3 weeks after.
Slovenian: Prvi dve injekciji je treba dati na izbrani datum, drugi dve injekciji pa po možnosti 3 tedne pozneje.
English: Your doctors know that this might happen and will have emergency treatment ready to use.
Slovenian: Vaš zdravnik ve, da se to lahko zgodi in bo imel nujna zdravila pripravljena za uporabo.
English: Vaccine distribution report
Slovenian: Poročilo o distribuciji cepiva
English: Persons not previously vaccinated with Prepandrix Adults from the age of 18 years:
Slovenian: Osebe, ki predhodno niso bile cepljene s cepivom Prepandrix Odrasli, starejši od 18 let:
English: - However, in a pandemic situation, you may still be given the vaccine.
Slovenian: - V pandemskih razmerah boste še vedno lahko prejeli cepivo.
English: “Cumulatively” means since the use of the vaccine; events not reported during the period of interest should not be presented in the tables.
Slovenian: - "Kumulativno" pomeni od uporabe cepiva; učinki, ki niso prijavljeni med proučevanim obdobjem, ne smejo biti vključeni v preglednice.
English: The report should include the following Tables of aggregate data (using the pre-defined templates attached in Annex 2).
Slovenian: Poročilo mora obsegati naslednje preglednice zbranih podatkov (z uporabo vnaprej opredeljenih predlog, priloženih v Dodatku 2).
English: It should be noted that the adverse reactions may be intensified.
Slovenian: Zavedati se je treba, da se neželeni učinki lahko stopnjujejo.
English: During the pandemic, the applicant will conduct a prospective cohort study as identified in the Pharmacovigilance plan.
Slovenian: Med pandemijo bo vlagatelj izvajal perspektivno kohortno študijo, kot je navedeno v načrtu farmakovigilance.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/09/578/001
Slovenian: ŠTEVILKA (ŠTEVILKE) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/09/578/001
English: The vaccine contains an ‘adjuvant' AS03.
Slovenian: Cepivo vsebuje "adjuvans" AS03.
English: The signs of pandemic flu are similar to those of ordinary flu but may be more serious.
Slovenian: Znaki pandemske gripe so podobni simptomom običajne gripe, vendar pa so običajno hujši.
English: The use of Adjupanrix may be considered during pregnancy if this is thought to be necessary, taking into account official recommendations.
Slovenian: Cepivo Adjupanrix se lahko uporabi med nosečnostjo, če se oceni, da je potrebno in ob upoštevanju uradnih priporočil.
English: Therefore tell the doctor or nurse if you fainted with a previous injection.
Slovenian: Zato morate zdravniku ali medicinski sestri povedati, če ste omedleli pri kakšni predhodni injekciji.
English: Allergic reactions which may cause you to have dangerously low blood pressure.
Slovenian: Alergijske reakcije, ki lahko povzročijo nevarno nizek krvni tlak.
English: Data obtained with the pandemic preparedness vaccine will support a vaccination strategy that is likely to be used for the pandemic vaccine: clinical immunogenicity, safety and reactogenicity data obtained with pandemic preparedness vaccines are relevant for the pandemic vaccines.
Slovenian: Podatki, pridobljeni s cepivom za pripravljenost na pandemijo, podpirajo strategijo cepljenja, ki bo verjetno uporabljena za pandemsko cepivo: podatki o klinični imunogenosti, varnosti in reaktogenosti, pridobljeni s cepivi za pripravljenost na pandemijo, so relevantni za pandemska cepiva.
English: These transitory false-positive results may be due to IgM production in response to the vaccine.
Slovenian: Prehodno lažno pozitivni rezultati so lahko posledica tvorbe IgM kot odziv na cepivo.
English: • if you have problems with your immune system, since your response to the vaccine may then be poor.
Slovenian: • če imate težave z imunskim sistemom, saj bo vaš odziv na cepivo lahko slabši.
English: It is best to see how Adjupanrix affects you before you try these activities.
Slovenian: Najbolje je, da ugotovite, kako cepivo Adjupanrix vpliva na vas, preden opravljate te dejavnosti.
English: Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines or have recently received any other vaccine.
Slovenian: Obvestite zdravnika ali medicinsko sestro, če jemljete, ste pred kratkim jemali, boste morda začeli jemati katero koli drugo zdravilo ali pa ste pred kratkim dobili kakršno koli drugo cepivo.
English: No fertility data are available.
Slovenian: Podatkov o plodnosti ni.
English: 71 to 80 years
Slovenian: 71 do 80 let
English: OTHER Storage (2ºC-8ºC), do not freeze, protect from light
Slovenian: Shranjevanje (2°C-8°C), ne zamrzujte, zaščitite pred svetlobo.
English: • Allergic reactions leading to a dangerously low blood pressure.
Slovenian: • Alergijske reakcije, ki nevarno znižajo krvni tlak.
English: Read all of this leaflet carefully before you start receiving this vaccine because it contains important information for you.
Slovenian: Preden dobite to cepivo, natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
English: After one priming dose
Slovenian: Po enem primarnem odmerku
English: Therefore, healthcare providers need to assess the benefits and potential risks of administering the vaccine in individuals with thrombocytopenia or any bleeding disorder that would contraindicate intramuscular injection unless the potential benefit outweighs the risk of bleedings.
Slovenian: Zato mora zdravnik oceniti koristi in možna tveganja uporabe cepiva pri posameznikih s trombocitopenijo ali kakršnokoli motnjo strjevanja krvi, ki bi bila kontraindikacija za intramuskularno injiciranje, razen če možna korist odtehta tveganje krvavitve.
English: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this vaccine.
Slovenian: Nosečnost in dojenje Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom, preden dobite to cepivo.
English: Frequency of submission
Slovenian: Pogostnost oddajanja